Avindra Nath MD
Clinical Director, National Institute of Neurological Disorders and Stroke (NINDS); Chief, Section of Infections of the Nervous System, National Institutes of Health, Bethesda, MarylandDr. Avindra Nath is a physician–scientist who specializes in the field of neuro-immunology and neurovirology. His research is focused on the clinical manifestations, pathophysiology and treatment of emerging neurological infections with a focus on HIV infection. In recent years, he has studied the neurological complications of endogenous retroviruses, Ebola, Zika virus, and SARS-CoV-2, and he conducts research on patients with undiagnosed neuroinflammatory disorders. He is internationally recognized for his contributions and has served on advisory committees to the NIH, CDC, FDA, and WHO.
Dr. Nath is the Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS) at NIH, where he is also Chief of the Section of Infections of the Nervous System, Director of the Translational Center for Neurological Sciences, and Director of the Neuroimmunology and Neurovirology Fellowship Program.
Disclosures
- Advisory boards: National Institutes of Health; Centers for Disease Control; Food and Drug Administration; World Health Organization
Recent Contributions to PracticeUpdate:
- An Overview of Neurological Manifestations of COVID-19
- The Evaluation of PML Lesions Using MRI in Patients With Multiple Sclerosis
- Neuropathology of Patients With COVID-19 in Germany
- Determination of Brain Death/Death by Neurologic Criteria
- Seasonal Influenza Vaccine and Guillain-Barré Syndrome
- WHO Grade Has No Prognostic Value in Pediatric Patients With High-Grade Glioma
- 2019 Top Stories in Neurology: Advances in the Treatment of Multiple Sclerosis
- Vaccination as a Risk Factor for Multiple Sclerosis
- AAN 2019: Recommendations From Dr. Avindra Nath
- The Microbiome and Infectious Etiologies for Multiple Sclerosis